Eli Lilly partners with Creyon Bio in $13M upfront deal, potential $1B+ milestone payments. CEO Serge Messerlian leads ...

GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today ...

Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that it is in contact with OTC Markets Group regarding the placement of a "Caveat ...

Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

Alexandria Real Estate Equities faces numerous challenges amid a slumping life sciences real estate market, per its Q1 2025 earnings call.

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-cl ...

today announced the grand opening of its newly expanded U.S. headquarters in San Diego's premier biotech corridor, marking a significant milestone in the company's North American expansion strategy.